Cipher Pharmaceuticals Inc.
CPH.TO
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 12.22M | 12.83M | 13.38M | 12.02M | 11.82M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 12.22M | 12.83M | 13.38M | 12.02M | 11.82M |
| Cost of Revenue | 2.30M | 2.35M | 2.50M | 2.88M | 5.13M |
| Gross Profit | 9.91M | 10.49M | 10.88M | 9.14M | 6.69M |
| SG&A Expenses | 3.68M | 3.71M | 4.09M | 4.82M | 4.85M |
| Depreciation & Amortization | 1.81M | 1.80M | 1.81M | 1.82M | 1.51M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.79M | 7.86M | 8.39M | 9.55M | 11.49M |
| Operating Income | 4.43M | 4.97M | 4.99M | 2.47M | 334.00K |
| Income Before Tax | 4.61M | 4.26M | 6.41M | 1.89M | -2.85M |
| Income Tax Expenses | -8.70M | -1.24M | 512.00K | -737.00K | -6.20M |
| Earnings from Continuing Operations | 13.31M | 5.50M | 5.89M | 2.62M | 3.34M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 13.31M | 5.50M | 5.89M | 2.62M | 3.34M |
| EBIT | 4.43M | 4.97M | 4.99M | 2.47M | 334.00K |
| EBITDA | 5.95M | 6.77M | 6.80M | 4.30M | 1.67M |
| EPS Basic | 0.52 | 0.22 | 0.23 | 0.10 | 0.13 |
| Normalized Basic EPS | 0.12 | 0.10 | 0.15 | 0.05 | -0.05 |
| EPS Diluted | 0.51 | 0.21 | 0.22 | 0.10 | 0.13 |
| Normalized Diluted EPS | 0.12 | 0.10 | 0.15 | 0.05 | -0.05 |
| Average Basic Shares Outstanding | 25.60M | 25.37M | 25.87M | 25.61M | 25.72M |
| Average Diluted Shares Outstanding | 26.10M | 25.95M | 26.51M | 26.20M | 25.72M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |